@article{c96a68cb537c47b3b2b8415385dd532e,
title = "Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012",
keywords = "Cancer Research, Oncology, Immunology, Immunology and Allergy, abatacept, B Raf kinase, B Raf kinase inhibitor, biological marker, CD40 ligand monoclonal antibody, docetaxel, epidermal growth factor receptor 2, immunological adjuvant, lymphocyte antigen receptor, n [3 (5 chloro 1h pyrrolo[2,3 b]pyridine 3 carbonyl) 2,4 difluorophenyl]propanesulfonamide, peptide vaccine, pertuzumab, trastuzumab, trastuzumab emtansine, algorithm, antibody engineering, automation, cancer immunization, cancer immunotherapy, castration resistant prostate cancer, cellular immunity, circulating tumor cell, conference paper, consensus development, data analysis software, disease course, disease marker, flow cytometry, glioblastoma, human, humoral immunity, immunogenicity, immunological monitoring, immunomodulation, medical research, nonhuman, personalized medicine, priority journal, vaccine production, Animals, Antineoplastic Agents, Cancer Vaccines, Germany, Humans, Immunotherapy, Individualized Medicine, Medical Oncology, Neoplasms, Synthetic Biology, Tumor Markers, Biological",
author = "Kloke, {Bj{\"o}rn Philipp} and Sarah Kutscher and Richard Rae and Pia Kvistborg and Britten, {Cedrik M.} and Hadrup, {Sine Reker}",
year = "2013",
doi = "10.1007/s00262-012-1386-2",
language = "English",
volume = "62",
pages = "975--981",
journal = "Cancer Immunology, Immunotherapy",
issn = "0340-7004",
publisher = "Springer",
number = "5",
}
